DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Le Tourneau C, Delord JP, Gonçalves A, Gavoille C, Dubot C, Isambert N, Campone M, Trédan O, Massiani MA, Mauborgne C, Armanet S, Servant N, Bièche I, Bernard V, Gentien D, Jezequel P, Attignon V, Boyault S, Vincent-Salomon A, Servois V, Sablin MP, Kamal M, Paoletti X.
SHIVA investigators. Molecularly targeted therapy based on tumour molecular
profiling versus conventional therapy for advanced cancer (SHIVA): a
multicentre, open-label, proof-of-concept, randomised, controlled phase 2
trial.
Lancet Oncol 2015;
16: 1324-1334
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.